SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001493152-20-003168
Filing Date
2020-02-28
Accepted
2020-02-28 17:31:08
Documents
1

Document Format Files

Seq Description Document Type Size
1 sc-13da.htm SC 13D/A 55894
  Complete submission text file 0001493152-20-003168.txt   57413
Mailing Address 3 FORBES ROAD LEXINGTON MA 02421
Business Address
ARMEN GARO H (Filed by) CIK: 0000935679 (see all company filings)

Type: SC 13D/A

Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Subject) CIK: 0001022899 (see all company filings)

IRS No.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-48089 | Film No.: 20672678
SIC: 7389 Services-Business Services, NEC